Health Disparities and World Health Day
There are important health disparities right here in southeastern Wisconsin.
April 10, 2019 • Read More
Symjepi: A new option for injectable epinephrine
The FDA has approved Symjepi, a new device for injectable epinephrine. Patients now have an additional option when choosing an epinephrine injector with their allergist.
March 18, 2019 • Read More
Wixela: Generic version of Advair now approved
The FDA has approved Wixela, a generic form of the Advair inhaler. With this generic, we will hopefully see some of the price relief we need in the treatment of asthma!
March 4, 2019 • Read More
FDA approves Primatene Mist
The Food and Drug Administration approved Primatene Mist for over-the-counter status. Allergists across the country are voicing their concerns about this decision.
November 12, 2018 • Read More
FDA alerts patients with EpiPens
The Food and Drug Administration alerts patients and providers that the labels on certain auto injectors may prevent easily removing the device from its carrier tube.
November 7, 2018 • Read More
Publication: Shared decision making for the allergist
Dr. Steven was the second author on a publication in the October 2018 Annals of Allergy, Asthma & Immunology for his contributions to the new shared decision making tool.
November 1, 2018 • Read More
Dupixent: New treatment for asthma
The FDA announced the approval of Dupixent (dupilumab), a new treatment for asthma. Unlike steroids, Dupixent targets just one component of asthmatic inflammation.
October 23, 2018 • Read More
Peanut Allergy Alert: Ice Cream Recall
Kemps is recalling Sweet Me Creamery Brookie Dough ice cream as certain lots may contain an undeclared peanut allergen. No other Sweet Me products have been affected.
October 22, 2018 • Read More
WANT TO READ EVEN MORE NEWS ARTICLES?
Visit the Allergy, Asthma & Sinus Center news archive to see all of our news items from the last two years.
Go to News Archive